Tight-lipped but Turbo Torrent Guns For Cipla

Since late May 2026, Maharashtra has been in the middle of one of its most aggressive food and drug enforcement drives in years — adulterated prasad seized near Shirdi, synthetic milk units shut down, the license of Mumbai’s Parsi Dairy Farm suspended, hospitals pulled up for for ...  Show more

In this conversation with ET's editor technology Surabhi Agarwal, Google Cloud CEO Thomas Kurian discusses the company's expanding footprint in India, including bringing Gemini Flash 3.5 and Gemini Enterprise to sovereign infrastructure, and scaling local engineering talent throu ...  Show more

India is set to reach a record year in initial public offerings and Big Pharma is facing a wave of patent expiration dates. Plus, Meta goes to trial over who to hold accountable for corporate scandals. Mentioned in this podcast:India on track for record IPO yearThe looming ‘paten ...  Show more

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billi ...  Show more

As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ...  Show more

Laura Chico, Biotechnology Research Analyst at Wedbush Securities and Bloomberg News US Deals Team Leader Matthew Monks share their thoughts on the Bristol Myers acquisition Karuna Therapeutics. John Mowrey, CIO at NFJ Investment Group, explains where to find value in the markets ...  Show more